Friday, October 30, 2026 · Edition updated 6:00 AM ETFRI, OCT 30 · 6 AM ET editionNext edition in Next --:--:--

Bioprinted bonoid-on-a-chip model for studying drug effects on human osteocyte differentiation

A study · Biofabrication · Jul 15, 2026

What this means

Osteocytes form an extensive dendritic network within bone tissue that senses mechanical and biochemical stimuli, critical for bone homeostasis. However, the complex interplay between mechanotransduction, oxygen tension, and osteocyte differentiation remains difficult to study due to the lack of physiologically relevant humanin vitromodels.

A plain-English summary is on its way. Until then, this is the start of the authors' own summary.

Tested inPeople
Who it was tested in
People
Kind of research
A study

The science

Original title
Bioprinted bonoid-on-a-chip model for studying drug effects on human osteocyte differentiation.
Authors
Scheinpflug J, Höfer CT, Steinfath M et al.
Journal
Biofabrication
Published
Jul 15, 2026
Study type
Study · in humans

Abstract

Osteocytes form an extensive dendritic network within bone tissue that senses mechanical and biochemical stimuli, critical for bone homeostasis. However, the complex interplay between mechanotransduction, oxygen tension, and osteocyte differentiation remains difficult to study due to the lack of physiologically relevant humanin vitromodels. Previously, we developed a microphysiological system (MPS) that integrates perfusion, mechanical loading, and oxygen control within a culture platform that enables the culture of bone-like three-dimensional (3D) constructs [1]. Here, we demonstrate the application of this MPS as Bonoid-on-a-chip (BoC)-platform to investigate osteoblast-to-early osteocyte transition and mechanosensitive signalling in a human-relevant 3D context, under different physical and chemical conditions. We generated bonoids by bioprinting primary human osteoblasts into a gelatine-hydrogel and cultured them under either static conditions or as dynamic BoC. Different BoC environments consisting in controlled perfusion (0.5 ml min-1), mechanical loading (0% or 10% compression, 1 Hz frequency), and physiological oxygen tension (21% or 12%) over a seven-day period were compared. These different models were additionally treated with dexamethasone (DEXA), to evaluate early osteocyte-targeted effects of drug exposure under these different conditions. We observed high cell viability across all conditions, but clear differences in metabolic activity, morphological changes, and mechanotransduction markers between static and dynamic cultures. Notably, cells within the BoC-platform exhibited extended dendritic processes and significantly increased secretion of prostaglandin E2 and nitrite in response to mechanical stimulation - hallmarks of osteocytic signalling in mechanotransduction. When testing the new BoC as platform for early osteocyte-targeted investigations, we found DEXA exposure disrupting this mechanoresponsive phenotype, highlighting the model's applicability for pharmacological screening. These findings demonstrate the value of our BoC-platform as a human-relevant model for studying bone mechanobiology and drug responsesin vitro. This approach offers a promising alternative to animal models in bone research and opens new avenues for investigating osteocyte function under physiologically dynamic conditions.

Read it on PubMed ↗

Scheinpflug J, Höfer CT, Steinfath M et al. Bioprinted bonoid-on-a-chip model for studying drug effects on human osteocyte differentiation. Biofabrication. 2026. doi:10.1088/1758-5090/ae7ed2. PMID: 42454519. https://pubmed.ncbi.nlm.nih.gov/42454519/

Related research

Study · Biology · Jul 15, 2026

Humanin treatment eased heart damage in diabetic mice

Mice with diabetes that got daily humanin for 15 days had less stress, inflammation, and cell death in the heart. This was tested in mice only, so it does not show the same would happen in people.

Study · Biomolecules · Jul 28, 2026

Humanin protein family may help steer cell stress responses

Researchers mapped how Humanin-related proteins connect to other proteins in a computer network. They suggest these proteins may guide stress responses, not just act alone. This is a model, so it does not show these proteins work this way in people.

Study · Reproduction (Cambridge, England) · Jul 3, 2026

Humanin, a small mitochondrial peptide, protected ovary cells from oxidative damage in lab tests

Researchers found that humanin helped human ovary cells and rat ovary tissue survive damage from oxidative stress. This was tested in cells and tissue, not people, so it does not show effects in humans.

Study · Antioxidants (Basel, Switzerland) · Aug 27, 2026

AGEs-RAGE Axis and Mitochondrial-Derived Peptides in Advanced Chronic Kidney Disease: Interconnected Pathways Beyond Inflammation and Nutrition.

Background. Chronic kidney disease [CKD] is characterized by increased glycoxidative stress, inflammation, and mitochondrial dysfunction.

Study · European journal of pharmacology · Jul 23, 2026

A humanin analog eased kidney damage in diabetic mice and cells

Researchers found a treated protein reduced kidney damage and cell death in diabetic mice. This work was in mice and cells, so it does not show the same effect in people.

Summary of earlier studiesReview · Epigenomics · Aug 11, 2026

Emerging regulators of human physiology and disease; sORF-encoded microproteins.

The human genome contains hundreds of thousands of short open reading frames (sORFs), yet their translational products, hereafter referred to as sORF-encoded microproteins (also historically termed micropeptides), have…

See all research on Humanin →

Report a problem